Plasma Cell‐Free DNA Concentration and Fragmentomes Predict Neoadjuvant Chemotherapy Response in Cervical Cancer Patients
Advanced Science · 2024-11 · 11 (43)
DOI: 10.1002/advs.202309422 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 25.09.2024. Verfasst von Ting Peng und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430000, China. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Neoadjuvant Therapy, Cell-Free Nucleic Acids, Biomarkers, Tumor. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Young Fund Cultivation Project, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Cervical cancer remains one of the most lethal gynecological malignancies. However, biomarkers for more precise patient care are an unmet need. Herein, the concentration of 285 plasma cell‐free DNA (cfDNA) samples are analyzed from 84 cervical patients and the clinical significance of cfDNA fragmentomic characteristics across the neoadjuvant chemotherapy (NACT) treatment. Patients with poor NACT response exhibit a significantly greater escalation in cfDNA levels following the initial cycle of treatment, in comparison to patients with a favorable response. Distinctive end motif profiles and promoter coverages of cfDNA in initial plasma are observed between patients with differing NACT responses. Notably, the DNASE1L3 analysis further demonstrates the intrinsic association between cfDNA characteristics and chemotherapy resistance. The cfDNA and motif ratios show a good discriminative capacity for predicting non‐responders from responders (area under the curve (AUC) > 0.8). In addition, transcriptional start sites (TSS) coverages around promoters discern the alteration of biological processes associated with chemotherapy resistance and reflect the potential value in predicting chemotherapy response. These findings in predictive biomarkers may optimize treatment selection, minimize unnecessary treatment, and assist in establishing personalized treatment strategies for cervical cancer patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430000, China.
- National Clinical Research Center for Gynecology and Obstetrics, Cancer Biology Research Center (Key Laboratory of the Ministry of Education), Tongji Hospital, Tongji Medical College, Huazhong University of Science and…
- BGI Research, Shenzhen, 518083, China.
- College of Life Sciences, University of Chinese Academy of Sciences, Beijing, 100049, China.
- Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430000, China.
- Department of Obstetrics and Gynecology, Affiliated Hospital of Jiangnan University, Wuxi Medical College, Jiangnan University, Wuxi, 214000, China.
ORCID-Profile: Peng Wu
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Young Fund Cultivation Project, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Zitieren
APA
Peng, T., Zhang, H., Li, L., Cao, C., Xu, M., Liu, X., Lin, S., Wu, P., Chu, T., Liu, B., Xu, Y., Zhang, Y., Wang, Y., Yu, J., Ding, W., Jin, X., & Wu, P. (2024). Plasma Cell‐Free DNA Concentration and Fragmentomes Predict Neoadjuvant Chemotherapy Response in Cervical Cancer Patients. Advanced Science, 11(43). https://doi.org/10.1002/advs.202309422
Vancouver
Peng T, Zhang H, Li L, Cao C, Xu M, Liu X, et al. Plasma Cell‐Free DNA Concentration and Fragmentomes Predict Neoadjuvant Chemotherapy Response in Cervical Cancer Patients. Advanced Science. 2024;11(43). doi:10.1002/advs.202309422
BibTeX
@article{Peng2024,
author = {Peng, Ting and Zhang, Haiqiang and Li, Lingguo and Cao, Canhui and Xu, Miaochun and Liu, Xiaojie and Lin, Shitong and Wu, Ping and Chu, Tian and Liu, Binghan and Xu, Yashi and Zhang, Yan and Wang, Yeqin and Yu, Jinjin and Ding, Wencheng and Jin, Xin and Wu, Peng},
title = {Plasma Cell‐Free DNA Concentration and Fragmentomes Predict Neoadjuvant Chemotherapy Response in Cervical Cancer Patients},
journal = {Advanced Science},
year = {2024},
volume = {11},
number = {43},
doi = {10.1002/advs.202309422}
}
EUVIMED